FDA Formula Allows Tweets About Products Without Excessive Risks
This article was originally published in The Gray Sheet
Executive Summary
FDA’s draft guidance on presenting product information on social media platforms with character-space limitations includes an equation for sending a tweet. Solving it for products with complex risk profiles could be a challenge.
You may also be interested in...
Will #Cures2015 Fix Twitter Promotion?
House 21st Century Cures discussion draft would adjust FDA promotion regulations for Twitter, requiring that information communicated through hyperlink be considered part of the original post.
FDA Twitter Guidance Lacks Flexibility, And May Be Unconstitutional, Critics Say
Stakeholders say the agency’s communication requirements for space-limited online platforms are too restricting and violate the First Amendment. Many of them are calling on the agency to withdraw the guidance and try again. The device industry has a comparatively toned down response so far, but wants more flexibility.
Third-Party Social Media: Firms Should Not Be Selective In Corrections
FDA’s draft guidance on correcting independent third-party misinformation about drugs and devices advises companies to address exaggerated efficacy claims as well as incorrect risk information.